Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Biogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.
What's Your Reaction?
like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0
